Received Jun 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y010306 | — |
No Additional AE; HCP called to report a 47 year old female received a dose of PROQUAD, caller stated this was a first dose. No side effects or symptoms reported. No additional information provided. No Additional AE/ No PQC.; This spontaneous report was received from a nurse and refers to a 47-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 05-Jun-2025, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 0.5 mL (lot #Y010306 and expiration date reported as 01-Dec-2025) (route of administration and vaccination site was not provided) administered for prophylaxis (product administered to patient of inappropriate age). The vaccine was reconstituted with sterile diluent, solution for injection. No side effects or symptoms were reported. No additional information was provided. No Additional adverse event (AE) and no product quality complaint (PQC) was noted (no adverse event).
Sterile diluent